Company: PCRX
Filing Date: 2025-04-29
Form Type: DEF 14A
Source: 0001104659-25-041219
Chunk: 109

Company: Pacira BioSciences, Inc.
Filing Date: 2025-04-29
Form: DEF 14A
Chunk 109
---
 ​                                  | ​ |     1,426,631 | ​ | ​ | ​ | ​                            | ​ | 3.1% | ​ | ​ |
| Charles A. Reinhart, III(16)​                                | ​ | ​ | ​                                  | ​ |       272,921 | ​ | ​ | ​ | ​                            | ​ | *    | ​ | ​ |
| Lauren Riker(17)​                                            | ​ | ​ | ​                                  | ​ |       123,215 | ​ | ​ | ​ | ​                            | ​ | *    | ​ | ​ |
| ALL DIRECTORS AND EXECUTIVE OFFICERS AS A GROUP (17 PERSONS) | ​ | ​ | ​                                  | ​ | 2,975,389(18) | ​ | ​ | ​ | ​                            | ​ | 6.4% | ​ | ​ |

* Less than 1% (1) This information is derived exclusively from a Schedule 13G/A filed by BlackRock, Inc. with the SEC on January 19, 2024, reporting on beneficial ownership as of December 31, 2023. (2) This information is derived exclusively from a Schedule 13G/A filed by The Vanguard Group with the SEC on February 13, 2024, reporting on beneficial ownership as of December 29, 2023. (3) Includes 29,386 shares of common stock issuable upon exercise of stock options and 5,230 shares of common stock issuable upon the vesting of RSUs that are exercisable/vesting within 60 days of April 17, 2025. (4) Includes 71,801 shares of common stock issuable upon exercise of stock options and 5,230 shares of common stock issuable upon the vesting of RSUs that are exercisable/vesting within 60 days of April 17, 2025. (5) Includes 29,386 shares of common stock issuable upon exercise of stock options and 5,230 shares of common stock issuable upon the vesting of RSUs that are exercisable/vesting within 60 days of April 17, 2025. (6) Includes 97,235 shares of common stock issuable upon exercise of stock options and 5,230 shares of common stock issuable upon the vesting of RSUs that are exercisable/vesting within 60 days of April 17, 2025. (7)